Brief: NLS Pharmaceutics Obtains License To Full Regulatory Data For Sanorex

NewcelX AG

12/03/2021 13:06

March 12 (Reuters) - NLS Pharmaceutics AG  NLSP.O :
    * NLS PHARMACEUTICS OBTAINS LICENSE TO FULL REGULATORY DATA
PACKAGE AND PROPRIETARY KNOW-HOW FOR SANOREX® (MAZINDOL)
    * NLS PHARMACEUTICS AG - AGREEMENT PROVIDES EXCLUSIVE RIGHTS
TO
ALL AVAILABLE DATA INCLUDED IN ORIGINAL NEW DRUG APPLICATION FOR
MAZINDOL IN U.S.
    * NLS PHARMACEUTICS - DEAL INCLUDES RIGHT TO SUBLICENSE OR
ASSIGN
LICENSE TO THIRD PARTIES, SUBJECT TO SUCH THIRD PARTIES MEETING
CERTAIN OBLIGATIONS

Source text for Eikon:  ID:nPn6pdp7ka 
Further company coverage:  NLSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))